Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001897612-26-000284·Immunocore Holdings plc
Schedule 13G ownership disclosure
IMMUNOCORE HOLDINGS PLC
ADR · CUSIP: 45258D105
Event date: 2025-12-31
- Filing-level shares
- 5,961,227
- Percent of class
- 11.8%
- T. Rowe Price Investment Management, Inc.
Shares: 5,961,227 · Class: 11.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001897612-26-000284
- Form type
- SCHEDULE 13G/A
- Filer
- Immunocore Holdings plc
- CIK
- CIK 1671927
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership